In contrast, both the pharmacological blockade with Rsv in AhR+/+ and AhR-/- after ischemia improved locomotor activity 24 h and five days later compared with the ischemic-AhR+/+ group (*p = 0.0149) (Fig 6A). This evidence concerns the gene AHR and ischemia.